mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival
- PMID: 30417160
- PMCID: PMC6223325
- DOI: 10.1016/j.cotox.2018.05.002
mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival
Abstract
The mechanistic (or mammalian) target of rapamycin (mTOR) and the adenosine monophosphate-activated protein kinase (AMPK) regulate cell survival and metabolism in response to diverse stimuli such as variations in amino acid content, changes in cellular bioenergetics, oxygen levels, neurotrophic factors and xenobiotics. This Opinion paper aims to discuss the current state of knowledge regarding how mTOR and AMPK regulate the metabolism and survival of brain cells and the close interrelationship between both signaling cascades. It is now clear that both mTOR and AMPK pathways regulate cellular homeostasis at multiple levels. Studies so far demonstrate that dysregulation in these two pathways is associated with neuronal injury, degeneration and neurotoxicity, but the mechanisms involved remain unclear. Most of the work so far has been focused on their antagonistic regulation of autophagy, but recent findings highlight that changes in protein synthesis, metabolism and mitochondrial function are likely to play a role in the regulatory effects of both mTOR and AMPK on neuronal health. Understanding the role and relationship between these two master regulators of cell metabolism is crucial for future therapeutic approaches to counteract alterations in cell metabolism and survival in brain injury and disease.
Keywords: adenosine monophosphate-activated protein kinase; autophagy; cell death; energy failure; glycolysis; mammalian target of rapamycin; mitochondria; nutrient deprivation.
Figures
Similar articles
-
Amino acids regulate energy utilization through mammalian target of rapamycin complex 1 and adenosine monophosphate activated protein kinase pathway in porcine enterocytes.Anim Nutr. 2020 Mar;6(1):98-106. doi: 10.1016/j.aninu.2019.12.001. Epub 2020 Jan 7. Anim Nutr. 2020. PMID: 32211535 Free PMC article.
-
An update on the molecular mechanism and pharmacological interventions for Ischemia-reperfusion injury by regulating AMPK/mTOR signaling pathway in autophagy.Cell Signal. 2023 Jul;107:110665. doi: 10.1016/j.cellsig.2023.110665. Epub 2023 Mar 31. Cell Signal. 2023. PMID: 37004834
-
Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.Mol Neurobiol. 2017 Jul;54(5):3825-3842. doi: 10.1007/s12035-016-9906-2. Epub 2016 Jun 20. Mol Neurobiol. 2017. PMID: 27324791 Free PMC article.
-
Insight on Transcriptional Regulation of the Energy Sensing AMPK and Biosynthetic mTOR Pathway Genes.Front Cell Dev Biol. 2020 Jul 29;8:671. doi: 10.3389/fcell.2020.00671. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32903688 Free PMC article. Review.
-
Cross-talk between AMPK and mTOR in regulating energy balance.Crit Rev Food Sci Nutr. 2012;52(5):373-81. doi: 10.1080/10408398.2010.500245. Crit Rev Food Sci Nutr. 2012. PMID: 22369257 Review.
Cited by
-
The Ameliorative Effect of Empagliflozin in Vigabatrin-Induced Cerebellar/Neurobehavioral Deficits: Targeting mTOR/AMPK/SIRT-1 Signaling Pathways.Molecules. 2022 Jun 7;27(12):3659. doi: 10.3390/molecules27123659. Molecules. 2022. PMID: 35744783 Free PMC article.
-
Tanshinone IIA regulates fibroblast proliferation and migration and post-surgery arthrofibrosis through the autophagy-mediated PI3K and AMPK-mTOR signaling pathway.Am J Transl Res. 2021 Feb 15;13(2):565-584. eCollection 2021. Am J Transl Res. 2021. PMID: 33594310 Free PMC article.
-
Whole-genome sequencing of copy number variation analysis in Ethiopian cattle reveals adaptations to diverse environments.BMC Genomics. 2024 Nov 15;25(1):1088. doi: 10.1186/s12864-024-10936-5. BMC Genomics. 2024. PMID: 39548375 Free PMC article.
-
The Athlete Gut Microbiome and its Relevance to Health and Performance: A Review.Sports Med. 2022 Dec;52(Suppl 1):119-128. doi: 10.1007/s40279-022-01785-x. Epub 2022 Nov 18. Sports Med. 2022. PMID: 36396898 Free PMC article. Review.
-
Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.Biomedicines. 2021 May 19;9(5):576. doi: 10.3390/biomedicines9050576. Biomedicines. 2021. PMID: 34069618 Free PMC article. Review.
References
-
- Morita M, Gravel SP, Chenard V, Sikstrom K, Zheng L, Alain T, Gandin V, Avizonis D, Arguello M, Zakaria C, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab. 2013;18:698–711. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous